These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22455637)

  • 41. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Daily variation of NTBC and its relation to succinylacetone in tyrosinemia type 1 patients comparing a single dose to two doses a day.
    Kienstra NS; van Reemst HE; van Ginkel WG; Daly A; van Dam E; MacDonald A; Burgerhof JGM; de Blaauw P; McKiernan PJ; Heiner-Fokkema MR; van Spronsen FJ
    J Inherit Metab Dis; 2018 Mar; 41(2):181-186. PubMed ID: 29170874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Newborn Screening for Hereditary Tyrosinemia Type I in Québec: Update.
    Giguère Y; Berthier MT
    Adv Exp Med Biol; 2017; 959():139-146. PubMed ID: 28755192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatorenal Tyrosinemia in Mexico: A Call to Action.
    Ibarra-González I; Ridaura-Sanz C; Fernández-Lainez C; Guillén-López S; Belmont-Martínez L; Vela-Amieva M
    Adv Exp Med Biol; 2017; 959():147-156. PubMed ID: 28755193
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary excretion of succinylacetone and delta-aminolevulinic acid in patients with hereditary tyrosinemia.
    Christensen E; Jacobsen BB; Gregersen N; Hjeds H; Pedersen JB; Brandt NJ; Baekmark UB
    Clin Chim Acta; 1981 Nov; 116(3):331-41. PubMed ID: 7296896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of propionylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia].
    Wu SN; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):561-5. PubMed ID: 23663331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters.
    Chace DH; Lim T; Hansen CR; De Jesus VR; Hannon WH
    Clin Chim Acta; 2009 Sep; 407(1-2):6-9. PubMed ID: 19545553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Simple and fast quantification of nitisone (NTBC) using liquid chromatography-tandem mass spectrometry method in plasma of tyrosinemia type 1 patients.
    Davit-Spraul A; Romdhane H; Poggi-Bach J
    J Chromatogr Sci; 2012 May; 50(5):446-9. PubMed ID: 22511487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.
    Jakobs C; Dorland L; Wikkerink B; Kok RM; de Jong AP; Wadman SK
    Clin Chim Acta; 1988 Feb; 171(2-3):223-31. PubMed ID: 3286060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Application of tandem mass spectrometry in diagnosis of organic acidemias].
    Han LS; Gao XL; Ye J; Qiu WJ; Gu XF
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):325-30. PubMed ID: 15924743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Jin J; Gu XF
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2122-6. PubMed ID: 19080473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and the importance of early treatment of tyrosinemia type 1: A case report.
    Škaričić A; Zekušić M; Fumić K; Rogić D; Uroić V; Petković Ramadža D; Žigman T; Barić I
    Clin Mass Spectrom; 2019 Apr; 12():1-6. PubMed ID: 34841073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
    Jakobs C; Sweetman L; Nyhan WL
    Prenat Diagn; 1984; 4(3):187-94. PubMed ID: 6463026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of urinary succinylacetone by capillary gas chromatography.
    Tuchman M; Whitley CB; Ramnaraine ML; Bowers LD; Fregien KD; Krivit W
    J Chromatogr Sci; 1984 May; 22(5):211-5. PubMed ID: 6725495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal and fetal tyrosinemia type I.
    Garcia Segarra N; Roche S; Imbard A; Benoist JF; Grenèche MO; Davit-Spraul A; Ogier de Baulny H
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S507-10. PubMed ID: 23250512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Liver failure with coagulopathy in an infant with tyrosinemia].
    Nussinovitch M; Campino G; Shapira R; Voluvitz B; Amir J
    Harefuah; 2001 Jul; 140(7):578-9, 680. PubMed ID: 11481954
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Application of gas chromatography-mass spectrometry analysis on urine filter paper in the high-risk screening and diagnosis of inherited metabolic diseases].
    Luo XP; Wang MT; Wei H; Liang Y; Wang HW; Lin HH; Dong YS; Liu WJ; Fang JM; Ning Q
    Zhonghua Er Ke Za Zhi; 2003 Apr; 41(4):245-8. PubMed ID: 14754523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Combined use of tandem mass spectrometry with urine gas chromatography/mass spectrometry is useful for diagnosis of inborn errors of metabolism in children].
    Xie LJ; Zhu JX; Zhu XD; Li HJ; Han LS; Gu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):31-4. PubMed ID: 18289467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel mutation causing mild, atypical fumarylacetoacetase deficiency (Tyrosinemia type I): a case report.
    Cassiman D; Zeevaert R; Holme E; Kvittingen EA; Jaeken J
    Orphanet J Rare Dis; 2009 Dec; 4():28. PubMed ID: 20003495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Screening for hereditary tyrosinemia and genotype analysis in newborns].
    Tong F; Yang R; Liu C; Wu D; Zhang T; Huang X; Hong F; Qian G; Huang X; Zhou X; Shu Q; Zhao Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 48(4):459-464. PubMed ID: 31901053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.